奥贝胆酸杂质7 | 1908444-28-9

• 物质功能分类: 有机原料 - 羧酸类化合物及衍生物
• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 类固醇和类固醇衍生物
• 中文名称: 奥贝胆酸杂质7
• 中文别名: 奥贝胆酸杂质
• 英文名称: 7-epi-Obeticholic acid 3-obeticholate ester
• 英文别名: (4R)-4-[(3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-3-[(4R)-4-[(3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]oxy-7-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
• CAS: 1908444-28-9
• 化学式: C₅₂H₈₆O₇
• 分子量: 823.2
• InChiKey: CJNVDKNEYRWTNW-GBWJVFIXSA-N

物化性质

• 沸点：
  842.5±50.0 °C(Predicted)
• 密度：
  1.13±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  12.2
• 重原子数：
  59
• 可旋转键数：
  12
• 环数：
  8.0
• sp3杂化的碳原子比例：
  0.96
• 拓扑面积：
  124
• 氢给体数：
  4
• 氢受体数：
  7

文献信息

• [EN] COMPOSITIONS OF OBETICHOLIC ACID AND METHODS OF USE<br/>[FR] COMPOSITIONS D'ACIDE OBÉTICHOLIQUE ET PROCÉDÉS D'UTILISATION
  申请人：INTERCEPT PHARMACEUTICALS INC

  公开号：WO2016176208A1

  公开（公告）日：2016-11-03

  The disclosure relates to obeticholic acid formulations with improved stability, dissolution, and/or solubility, methods of preparing the same for use and methods of treating various diseases and conditions.

  该披露涉及到改善稳定性、溶解度和/或溶解性的欧贝替胆酸制剂，以及制备这些制剂用于治疗各种疾病和病况的方法。
• Compositions of obeticholic acid and methods of use
  申请人：Intercept Pharmaceuticals, Inc.

  公开号：US10052337B2

  公开（公告）日：2018-08-21

  The disclosure relates to obeticholic acid formulations with improved stability, dissolution, and/or solubility, methods of preparing the same for use and methods of treating various diseases and conditions.

  本公开涉及具有更好稳定性、溶解性和/或可溶性的顺苯乙醇酸制剂，制备其用途的方法，以及治疗各种疾病和病症的方法。
• Film-coated tablet having high chemical stability of active ingredient
  申请人：Intercept Pharmaceuticals, Inc.

  公开号：US11331273B2

  公开（公告）日：2022-05-17

  The present invention relates to a film-coated tablet having a high chemical stability of an active ingredient, said film-coated tablet comprising: (a) a tablet core containing obeticholic acid or a pharmaceutically acceptable salt thereof; and (b) a coating layer, which is provided on the surface of the tablet core, containing a film base and being substantially free from any plasticizer or containing at least one kind of specific plasticizer.

  本发明涉及一种活性成分化学稳定性高的薄膜包衣片剂，所述薄膜包衣片剂包括：(a) 片芯，含有顺苯乙醇酸或其药学上可接受的盐；(b) 包衣层，设置在片芯表面，含有膜基，基本上不含任何增塑剂或含有至少一种特定增塑剂。
• COMPOSITIONS OF OBETICHOLIC ACID AND METHODS OF USE
  申请人：Intercept Pharmaceuticals, Inc.

  公开号：EP3288958A1

  公开（公告）日：2018-03-07
• METHODS OF USING OBETICHOLIC ACID
  申请人：Intercept Pharmaceuticals, Inc.

  公开号：US20200147108A1

  公开（公告）日：2020-05-14

  The disclosure relates to methods of using obeticholic acid or pharmaceutically acceptable salt or amino acid conjugate thereof for slowing down or reversing the progression of compensated cirrhosis.